| Literature DB >> 28959649 |
Atish Kumar Sahoo1, Umesh Chandra Dash1, Satish Kanhar1, Ajay Kumar Mahapatra2.
Abstract
Homalium zeylanicum (Gardner) Benth. (Flacourtiaceae) is a medicinal plant useful in controlling rheumatism, inflammation and diabetes. The objective of this work evaluates in vitro antioxidant, antidiabetic, and antiinflammatory properties of hydroalcohol extract of bark of H. zeylanicum (HAHZ). It also describes isolation and structure determination of lucidenic acid A, which is the first report in this plant. In order to explain the role of antioxidant principles, DPPH, nitric oxide, hydroxyl, superoxide and metal chelating assays were performed. Antidiabetic and anti-inflammatory activities were investigated by quantifying α-amylase, α-glucosidase and protein denaturation inhibitory activities of HAHZ. Biochemical estimations were performed. The chemical structure of the triterpenoid was elucidated using 1H, 13C NMR and high resolution-MS. IC50 of DPPH, nitric oxide, hydroxyl, superoxide and metal chelating activities were of 36.23 ± 0.27, 40.11 ± 0.32, 35.23 ± 0.57, 43.34 ± 0.22 and 11.54 ± 0.08 μg/mL, respectively. IC50 of α-amylase and α-glucosidase activities were 29.12 ± 0.54, and 18.55 ± 0.15 μg/mL. Total phenolic and total flavonoid contents were recorded at 233.65 mg/g GAE and 172.7 mg/g QE. Regarding kinetic behaviour, HAHZ showed competitive inhibition on α-glucosidase and mixed competitive inhibition on α-amylase. Lucidenic acid A was confirmed by spectroscopic studies. Anti-inflammatory activity of lucidenic acid A was determined by using protein denaturation assay with IC50 13 μg/mL but HAHZ showed 30.34 ± 0.13 μg/mL. Phenols and flavonoids could be attributed to inhibition of intestinal carbohydrases for anti-diabetic activities whereas triterpenoids could be responsible for anti-inflammatory activity of H. zeylanicum.Entities:
Keywords: α -amylase; -glucosidase; Antidiabetic; Antiinflammatory; DNS, dinitrosalicylic; DPPH, 2,2-diphenyl-1-picrylhydrazyl; Diclofenac sodium (PubChem CID: 5018304); EDTA (PubChem CID: 6049); GAeqv/g, gallic acid equivalents per gram; HAHZ, hydro alcoholic extract of Homalium zeylanicum; Homalium zeylanicum; IC50, half maximal inhibitory concentration; Lucidenic acid A (PubChem CID: 14109375); Lucidenic acid a; NBT, nitroblue tetrazolium; NO, Nitric oxide; NSAIDs, nonsteroidal anti-inflammatory drugs; OH, hydroxyl; PBS, phosphate buffer saline; PMS, phenazine methosulphate; Queqv/g, Quercetin equivalents per gram; Quercetin (PubChem CID: 5280343); ROS, reactive oxygen species; Rf, Retardation factor; SOD, superoxide anion; TFC, total flavonoid contents; TLC, thin layer chromatography; TPC, total phenolic contents; acarbose (PubChem CID: 41774); gallic acid (PubChem CID: 370); pNPG, p-nitrophenyl-α-d-glucopyranoside
Year: 2017 PMID: 28959649 PMCID: PMC5615128 DOI: 10.1016/j.toxrep.2017.04.004
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
In vitro antioxidant, anti-diabetic, and anti-inflammatory studies of hydroalcohol extract of bark of Homalium zeylanicum and lucidenic acid A.
| HAHZ | Standard | |
|---|---|---|
| DPPH | 36.23 ± 0.27 | 25.12 ± 0.07 |
| NO | 40.11 ± 0.32 | 24.13 ± 0.11 |
| OH | 35.23 ± 0.57 | 28.24 ± 0.17 |
| SOD | 43.34 ± 0.22 | 26.21 ± 0.13 |
| Metal chelating | 11.54 ± 0.08 | 12.27 ± 0.04 |
| α-amylase | 29.12 ± 0.54 | 19.89 ± 0.21 |
| α-glucosidase | 18.55 ± 0.15 | 16.02 ± 0.24 |
| Protein Denaturation | 30.34 ± 0.13 | 10.16 ± 0.12 |
| 13.56 ± 0.10 (Lucidenic acid A) | ||
Standard drug ascorbic acid was considered for DPPH and, hydroxyl radical scavenging assays. For nitric oxide, superoxide dismutase assays, quercetin was considered as a standard drug. For metal chelating assay, EDTA was considered as a standard drug to perform the assay. For anti-diabetic study, acarbose was considered as a standard drug for both α-amylase and α-glucosidase assays. For protein denaturation anti-inflammatory study, diclofenac sodium was considered as a standard drug to perform the assay. HAHZ is the hydroalcohol extract of bark of H. zeylanicum. However, the isolated Lucidenic acid A did not show in vitro antioxidant and anti-diabetic activities.
Fig. 1In vitro anti-diabetic activity of hydroalcohol extract of bark of Homalium zeylaicum (HAHZ). Reducing power was measured at different concentration of HAHZ (10–100 μg/mL) for α-amylase and α-glucosidase assays. Acarbose was considered as control for both assays. Values were the mean of triplicate experiments for both α-amylase and α-glucosidase assays. The result represents as mean ± SEM (n = 3). IC50 value of HAHZ was found to be significantly compared (p < 0.05) to the standard drug acarbose in one way ANOVA test. Student’s t-test was performed to analyze this data set (SPSS, Version 11).
Fig. 3Lineweaver-Burk plots of α-amylase and α-glucosidase (Vmax of 0.55 approx.) and (Vmax of 0.45 approx.) activities over a range of substrate concentrations (10–50 mM) in the absence (Control) or presence of hydroalcohol extract of bark of Homalium zeylaicum (HAHZ). The graph depicts competitive (reversible) mode of inhibition of α-glucosidase and mixed competitive mode of inhibition of α-amylase.
Fig. 2In vitro anti-inflammatory activities of hydroalcohol extract of bark of Homalium zeylaicum (HAHZ). The protein denaturation was measured at different concentration of HAHZ (10–100 μg/mL) and compound 1 (10–100 μg/mL). Diclofenac sodium was taken as standard for this assay. Values are the mean of triplicate experiments for this assay and represented as mean ± SEM (n = 3). IC50 values of two different groups as HAHZ and compound 1 were significantly compared (p < 0.05) to diclofenac sodium standard group in one way ANOVA test. Student’s t-test was performed to analyze this data set (SPSS, Version 11).
Fig. 4Fingerprint and standardisation of HAHZ. Slide A: Fingerprint of HAHZ at two different concentrations (chloroform:ethylacetate:formic acid; 4:5:1) at 254 nm Slide B: Standardisation of compound 1 with HAHZ (chloroform:hexane; 1:1; Rf = 0.2) at 254 nm Slide C: Standardisation of compound 1 with HAHZ (chloroform:hexane; 1:1; Rf = 0.2) at 365 nm. HAHZ is the hydroalcohol extract of bark of Homalium zeylaicum.
Fig. 5Lucidenic acid A.
1H NMR and 13C NMR spectral data of compounds 1.
| 1H NMR (δ in ppm) | 13C NMR (δ in ppm) | ||
|---|---|---|---|
| 1H (α) | 1.70 | C1 | 30.2 (2) |
| 1H (β) | 1.972 | C2 | 33.9 (2) |
| 2H (α) | 2.194 | C3 | 213.6 (0) |
| 2H (β) | 2.198 | C4 | 46.9 (0) |
| 5H | 2.999 (dd) | C5 | 49.5 (1) |
| 6H (α) | 2.248 (dd) | C6 | 26.9 (2) |
| 6H (β) | 2.267 (dd) | ||
| 7H | 4.603 | C7 | 65.5 (1) |
| 12H (α) | 1.282 | C8 | 156.8 (0) |
| C9 | 140.2 (0) | ||
| C10 | 37.8 (0) | ||
| C11 | 196.7 (0) | ||
| C12 | 51.3 (2) | ||
| C13 | 48.4 (0) | ||
| C14 | 55.9 (0) | ||
| C15 | 215.6 (0) | ||
| 16H (α)- | 1.280 | C16 | 42.7 (2) |
| 16H (β)- | 1.282 | ||
| 17H | 1.467 | C17 | 47.2 (1) |
| 18CH3 | 0.671 | C18 | 18.1 (3) |
| 19CH3 | 1.282 | C19 | 18.8 (3) |
| 20H | 1.48 (m) | C20 | 36.3 (1) |
| 21CH3 | 0.89 (d) | C21 | 17.3 (3) |
| 22H | 1.197-1.249 (m) | C22 | 31.5 (2) |
| 23H | 2.99 & 3.17 (m) | C23 | 37.3 (2) |
| 24H | 7.26 (s) | C24 | 181.6 (0) |
| 25CH3 | 1.18 (s) | C25 | 24.1 (3) |
| 26CH3 | 1.19 (s) | C26 | 21.5 (3) |
| 27CH3 | 0.96 (s) | C27 | 28.4 (3) |